Kiromic BioPharma, Inc. (KRBP)
Largest Insider Buys in Sector
KRBP Stock Price History Chart
KRBP Stock Performance
About Kiromic BioPharma, Inc.
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and …
Insider Activity of Kiromic BioPharma, Inc.
Over the last 12 months, insiders at Kiromic BioPharma, Inc. have bought $58,621 and sold $0 worth of Kiromic BioPharma, Inc. stock.
On average, over the past 5 years, insiders at Kiromic BioPharma, Inc. have bought $52,764 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: BERSANI PIETRO (CEO) — $26,937. Hungerford Brian (CFO) — $18,082. Misajon Pamela (director) — $10,272.
The last purchase of 988 shares for transaction amount of $1,907 was made by BERSANI PIETRO (Chief Executive Officer) on 2024‑08‑26.
List of Insider Buy and Sell Transactions, Kiromic BioPharma, Inc.
| 2024-08-26 | Chief Executive Officer | 988 0.6887% | $1.93 | $1,907 | -42.49% | |||
| 2024-08-23 | Chief Executive Officer | 2,500 1.9866% | $2.20 | $5,500 | -49.32% | |||
| 2024-08-20 | Chief Financial Officer | 3,742 2.9694% | $2.20 | $8,221 | -48.39% | |||
| 2024-08-19 | Chief Financial Officer | 258 0.2097% | $2.25 | $581 | -50.22% | |||
| 2024-08-13 | Chief Financial Officer | 2,000 1.2642% | $1.75 | $3,500 | +7.55% | |||
| 2024-06-13 | CFO | 1,000 0.9391% | $2.60 | $2,600 | -43.46% | |||
| 2024-06-12 | CEO | 3,000 3.5541% | $3.28 | $9,840 | -37.92% | |||
| 2024-06-12 | CFO | 1,000 1.1486% | $3.18 | $3,180 | -37.92% | |||
| 2024-06-12 | director | 1,610 1.9101% | $3.28 | $5,288 | -37.92% | |||
| 2024-06-11 | CEO | 3,000 3.5% | $3.23 | $9,690 | -54.56% | |||
| 2024-06-11 | director | 1,000 1.2028% | $3.33 | $3,330 | -54.56% | |||
| 2024-06-10 | director | 1,701 1.8002% | $2.93 | $4,984 | -46.81% | |||
| 2021-09-09 | CHIEF EXECUTIVE OFFICER | 2,800 0.0006% | $3.70 | $10,357 | -77.43% | |||
| 2021-05-24 | director | 5,000 0.0021% | $7.31 | $36,550 | -74.05% |
Insider Historical Profitability
| BERSANI PIETRO | Chief Executive Officer | 142333 9.207% | $0.90 | 4 | 0 | |
| Hungerford Brian | Chief Financial Officer | 64933 4.2003% | $0.90 | 5 | 0 | |
| NAGEL MICHAEL | director | 43296 2.8007% | $0.90 | 1 | 0 | |
| Misajon Pamela | director | 28811 1.8637% | $0.90 | 2 | 0 | |
| Chiriva Internati Maurizio | CHIEF EXECUTIVE OFFICER | 1378072 89.1425% | $0.90 | 1 | 0 |